Search results

Selected filters:

Valuation

Article type

Topic

Sector

Regions

1,320 results found for your search

Sort options
17 May 2019

The pledge that may reduce Tesla’s value as it seeks additional funds

In 2014, Elon Musk vowed not to sue anyone for patent infringement if they used the company’s technology in “good faith”. Five years later and that may not look to be such a great idea

09 May 2019

Inside the IBM patent factory

Although it has been the number one recipient of US grants every year this century and before, Big Blue’s abandonment strategy means its portfolio is not America’s biggest. It has also been quietly recalibrating its holdings

08 May 2019

Over 70 IP business leaders confirmed to speak at IPBC Global 2019

The world's leading event about IP value creation is taking place in Boston at the Westin Waterfront from 16th to 18th June, with over 500 delegates already signed up and space for more limited

07 May 2019

Faraday Future seeks lifeline from $1.25 billion IP valuation

Cash-strapped electric vehicle start-up hopes to attract much-needed funding after Houlihan Lokey estimate of the value of its portfolio, which includes tech, patents and trademarks 

23 April 2019

As more details emerge of its settlement with Apple, things look even better for Qualcomm

The chipmaker looks to have secured close to what it wanted from the royalty agreement, while its technology and patent strategy have been fully vindicated

05 April 2019

Future of former Yahoo! patents comes back on the agenda 

No free passes insists Excalibur head as he contemplates future of $250m portfolio after parent company announces dissolution

05 April 2019

Analysis of Fujifilm’s portfolio shows R&D strategy has opened doors to high-growth industries

The Japanese photography and imaging company has focused on developing peripheral technologies to expand into the medical and pharmaceuticals sectors; but while its holdings have increased in quality over the years, it still has a way to go

26 March 2019

Top state life sciences R&D deal-maker explains how to overcome patent barriers to partnerships

A*STAR’s head of IP and corporate services Suresh Sachi sets out his approach to partnering with biopharma innovators, the exclusivity-related stumbling blocks – and how to overcome them

14 March 2019

New research highlights impact of patent eligibility uncertainty on life sciences and tech investments

Academic calls for Congress to act on 101 “to restore investor confidence” with private equity and VC players clear that doubts over patentability make it less likely they will part with cash

06 March 2019

The state of play in the global IP market

IAM's annual benchmarking survey is designed to identify the key concerns of senior decision makers in areas such as deal-making, valuation, patent office performance, top litigation venues and policy 

05 March 2019

It turns out John Amster was absolutely right about RPX

The former CEO was fired after recommending that the firm should go private, but 18 months later it happened anyway and the defensive patent aggregator now appears to be thriving 

04 March 2019

Pharma patent licensing surge falters

High asset valuations and a loss of momentum in the oncology space seem to be behind a sharp fall in transactions

01 March 2019

TiVo delays decision on split, but product and IP business divide appears increasingly likely

As key litigation battle goes on company reveals fourth quarter drop in licensing revenues

21 February 2019

Startups from Southeast Asia have little to fear from IP but much to gain

At IPBC Southeast Asia, members of the region’s dynamic startup ecosystem heard that while IP may not yet be a critical threat to their business, it presents unique opportunities

13 February 2019

IPBC Global 2019 is shaping up to be the biggest and best of the series so far

Senior decision makers from a wide range of companies are already confirmed to attend as demand for tickets exceeds the rate for last year's sell-out event in San Francisco